Filter
719
Text search:
drug
formulations
Featured
Recommendations
91
New Publications
210
Language
Document type
No document type
399
Guidelines
150
Studies & Reports
94
Manuals
37
Training Material
13
Strategic & Response Plan
10
Fact sheets
9
Situation Updates
2
Resource Platforms
2
Brochures
1
App
1
Infographics
1
Countries / Regions
India
51
Kenya
28
Global
23
Ethiopia
15
South Africa
15
Malawi
15
Western and Central Europe
12
Africa
12
Tanzania
11
Uganda
10
Nepal
10
Bangladesh
10
Sierra Leone
9
Nigeria
8
Zimbabwe
8
Zambia
8
Namibia
8
Liberia
7
Ghana
7
Philippines
7
Rwanda
7
Myanmar / Burma
7
South–East Asia Region
6
Latin America and the Carribbean
6
Eastern Europe
6
Cameroon
4
Cambodia
4
Eswatini/ Swaziland
4
Senegal
3
Haiti
3
Syria
3
Benin
3
Botswana
3
Burkina Faso
2
Indonesia
2
East and Southern Africa
2
Middle East and North Africa
2
Russia
2
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Pakistan
1
South Sudan
1
Afghanistan
1
Thailand
1
Malaysia
1
Mozambique
1
Argentina
1
Peru
1
Brazil
1
Ukraine
1
Colombia
1
Bolivia
1
Madagascar
1
Lesotho
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Venezuela
1
Congo-Brazzaville
1
Tajikistan
1
Australia
1
Georgia
1
North America
1
France
1
Authors & Publishers
Publication Years
Category
Countries
258
Clinical Guidelines
129
Women & Child Health
33
Public Health
32
Key Resources
19
Pharmacy & Technologies
15
Capacity Building
9
Toolboxes
HIV
105
TB
92
Pharmacy
63
AMR
40
Mental Health
32
NTDs
32
COVID-19
15
NCDs
15
Malaria
13
Rapid Response
9
Caregiver
9
Ebola & Marburg
8
Refugee
5
Planetary Health
5
Disability
4
Conflict
4
2.0 Rapid Response
4
Cholera
3
Polio
3
Health Financing Toolbox
3
Zika
2
Specific Hazards
2
Global Health Education
2
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
Indoor residual spraying (IRS) involves applying residual insecticide to potential vector resting sites on the interior surfaces of human dwellings or other buildings. The main aim of IRS is to kill vectors before they are able to transmit pathogens to humans. When carried out correctly, IRS has his
...
Le paludisme, appelé également malaria, ou « Mal‘aria », ce qui signifie « mauvais air
», est une maladie qui menace 3 milliards de personnes dans 99 pays dans le monde.1
Les personnes les plus vulnérables sont les jeunes enfants et les femmes enceintes,
car c’est parmi cette populatio
...
The document outlines essential steps and provides guidance to countries on the adoption and deployment of c-IPTp so that it is integrated into the existing health system. It draws upon best practices and lessons learned from pilot implementation experiences in eight African countries and targets st
...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages
...
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat
...
These guidelines, produced in 2022 by the Uganda Ministry of Health, provide guidance on the diagnosis of HIV, the care of people living with HIV, and the use of antiretroviral drugs for treating and preventing HIV infection, including injectable cabotegravir and the dapivirine vaginal ring.